What do you and your colleagues have to say?

Quick Poll

What do YOU think about FDA's recent actions on diagnostics and lab-developed tests?
Read OT's feature report on reactions from the medical community on the most recent steps by the U.S. Food and Drug Administration that will affect approvals of companion diagnostics, and will likely lead to more oversight of LDTs. What do YOU think?

Will these actions slow down the development of novel drugs and therapeutics?
Will these actions slow down the development of novel drugs and therapeutics?
Will these actions slow down the development of novel drugs and therapeutics?
Will these actions slow down the development of novel drugs and therapeutics?
 Submit
 Clear
 Results

Read OT's coverage of this and other top issues in oncology/hematology in our CURRENT ISSUE...

 

ISSN: 0276-2234
Online ISSN: 1548-4688